Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCCI
1076
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $10.1M | 0.01% |
311,300
-126,600
| -29% | -$3.81M |
|
1077
Ternium
TX
$10.8B
| $10.1M | 0.01% |
330,500
-32,200
| -9% | -$963K |
|
1078
Harmonic Inc
HLIT
$1.42B
| $10M | 0.01% |
766,127
+640,600
| +510% | +$8.94M |
|
|
CSII
1079
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.98M | 0.01% |
732,958
-148,573
| -17% | -$2.07M |
|
1080
FIGS
FIGS
$2.47B
| $9.98M | 0.01% |
1,483,000
+526,700
| +55% | +$3.79M |
|
1081
AXIS Capital
AXS
$7.26B
| $9.94M | 0.01% |
183,496
-25,300
| -12% | -$1.37M |
|
|
WW
1082
DELISTED
WW International
WW
| $9.93M | 0.01% |
2,573,612
+642,700
| +33% | +$2.58M |
|
1083
Orthofix Medical
OFIX
$415M
| $9.9M | 0.01% |
482,290
-14,900
| -3% | -$263K |
|
|
NVRO
1084
DELISTED
NEVRO CORP.
NVRO
| $9.9M | 0.01% |
249,900
+220,200
| +741% | +$9.16M |
|
1085
PubMatic
PUBM
$783M
| $9.89M | 0.01% |
772,448
+18,348
| +2% | +$288K |
|
|
FORG
1086
DELISTED
ForgeRock, Inc.
FORG
| $9.89M | 0.01% |
+434,200
| New | +$9.46M |
|
1087
Centrus Energy
LEU
$3.83B
| $9.85M | 0.01% |
303,335
-5,500
| -2% | -$210K |
|
|
SCPL
1088
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $9.84M | 0.01% |
611,900
-28,700
| -4% | -$416K |
|
1089
Sea Limited
SE
$75.5B
| $9.83M | 0.01% |
+189,000
| New | +$10.2M |
|
1090
Pilgrim's Pride
PPC
$6.57B
| $9.83M | 0.01% |
414,113
-369,000
| -47% | -$8.8M |
|
|
SPLK
1091
DELISTED
Splunk Inc
SPLK
| $9.81M | 0.01% |
114,000
+55,500
| +95% | +$4.48M |
|
|
MCBC
1092
DELISTED
Macatawa Bank Corp
MCBC
| $9.81M | 0.01% |
889,359
-42,958
| -5% | -$456K |
|
|
FLIC
1093
DELISTED
First of Long Island Corp
FLIC
| $9.78M | 0.01% |
543,450
-39,400
| -7% | -$715K |
|
|
LPRO
1094
DELISTED
Open Lending Corp
LPRO
| $9.75M | 0.01% |
1,444,925
+166,600
| +13% | +$1.17M |
|
|
JKS
1095
JinkoSolar
JKS
$860M
| $9.75M | 0.01% |
238,452
-48,648
| -17% | -$2.34M |
|
|
PDCO
1096
DELISTED
Patterson Companies, Inc.
PDCO
| $9.73M | 0.01% |
347,204
+140,200
| +68% | +$3.87M |
|
1097
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $9.73M | 0.01% |
198,500
+179,300
| +934% | +$8.77M |
|
1098
Western Alliance Bancorporation
WAL
$8.92B
| $9.7M | 0.01% |
+162,904
| New | +$10.6M |
|
|
APLS
1099
DELISTED
Apellis Pharmaceuticals
APLS
| $9.69M | 0.01% |
187,413
-157,700
| -46% | -$8.36M |
|
|
VRTV
1100
DELISTED
VERITIV CORPORATION
VRTV
| $9.69M | 0.01% |
79,600
-28,700
| -27% | -$3.48M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.